Summary & Overview

Full Thickness Burn without Skin Graft or Inhalation Injury: Inpatient Reimbursement Overview

DRG 934 addresses hospital stays for full thickness burns without skin graft or inhalation injury and defines the clinical services and resource use grouped for payment. Proper assignment matters for inpatient reimbursement because it determines the Diagnosis-Related Group payment and reflects the case mix and expected hospital resource consumption.

DRG Full Thickness Burn without Skin Graft or Inhalation InjuryDRG 934Diagnosis-Related GroupInpatient ReimbursementMedicareBurn SurgeryWound CareSurgical NursingCritical Care

DRG 934 Overview

DRG 934 covers patients hospitalized for full thickness burn injuries that do not require a skin graft and have no inhalation injury documented. This Diagnosis-Related Group captures the inpatient resource use related to surgical and wound care, fluid management, pain control, and infection prevention specific to full thickness burns. It matters for Medicare payment because classification into this Diagnosis-Related Group determines the bundled prospective payment amount for the hospital stay. Accurate coding of burn depth, procedures, and associated complications or comorbidities affects reimbursement and case mix classification.

Clinical Trials

Acute wound care device trials investigating novel dressings, negative-pressure wound therapy modifications, or biologic matrices for managing full-thickness burns without grafting. These studies enroll hospitalized adult and pediatric patients with deep second-degree to third-degree burns who are being managed conservatively (no immediate autograft) to assess healing time, infection rates, need for later grafting, and pain control. Results inform inpatient resource use, length of stay, and short-term cost drivers important to hospital administrators and payers determining bundled payment and coverage decisions for non-operative burn management.
Comparative effectiveness studies evaluating non-surgical versus delayed-surgical pathways and protocols (for example, standardized conservative care bundles versus early excision and graft avoidance strategies) focused on functional and cosmetic outcomes. These trials typically include patients with medium-sized full-thickness burns where the indication for grafting is unclear, comparing outcomes such as time to epithelialization, scar quality, rehospitalization, and rehabilitation needs. Findings help clinicians decide optimal care pathways and help payers and case managers predict downstream utilization, rehabilitation needs, and long-term disability costs.
Post-discharge observational cohorts and outcomes research assessing long-term functional recovery, psychosocial impact, and health service utilization among survivors of full-thickness burns who did not undergo skin grafting. These studies follow patients after hospital discharge to measure return to work, need for outpatient wound care or reconstructive procedures, chronic pain, scar management interventions, and health-related quality of life over months to years. This evidence is relevant for payers and health systems planning post-acute coverage, outpatient service capacity, and cost-effectiveness of early interventions that could reduce long-term morbidity and readmissions.

Clinical Trials

Acute wound care device trials investigating novel dressings, negative-pressure wound therapy modifications, or biologic matrices for managing full-thickness burns without grafting. These studies enroll hospitalized adult and pediatric patients with deep second-degree to third-degree burns who are being managed conservatively (no immediate autograft) to assess healing time, infection rates, need for later grafting, and pain control. Results inform inpatient resource use, length of stay, and short-term cost drivers important to hospital administrators and payers determining bundled payment and coverage decisions for non-operative burn management.
Comparative effectiveness studies evaluating non-surgical versus delayed-surgical pathways and protocols (for example, standardized conservative care bundles versus early excision and graft avoidance strategies) focused on functional and cosmetic outcomes. These trials typically include patients with medium-sized full-thickness burns where the indication for grafting is unclear, comparing outcomes such as time to epithelialization, scar quality, rehospitalization, and rehabilitation needs. Findings help clinicians decide optimal care pathways and help payers and case managers predict downstream utilization, rehabilitation needs, and long-term disability costs.
Post-discharge observational cohorts and outcomes research assessing long-term functional recovery, psychosocial impact, and health service utilization among survivors of full-thickness burns who did not undergo skin grafting. These studies follow patients after hospital discharge to measure return to work, need for outpatient wound care or reconstructive procedures, chronic pain, scar management interventions, and health-related quality of life over months to years. This evidence is relevant for payers and health systems planning post-acute coverage, outpatient service capacity, and cost-effectiveness of early interventions that could reduce long-term morbidity and readmissions.

OpenPayer

Summary & Overview

Full Thickness Burn without Skin Graft or Inhalation Injury: Inpatient Reimbursement Overview

DRG 934 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes